Some data indicated SMARCA2/BRM as a tumour suppressor or tumour susceptibility gene, whereas overexpression of BRM caused cancer resistance for chemotherapy leading to cancer progression indicating its promoting role. The gene discussed is SMARCA2; the disease is neoplasm.